| Aug 15 |
Karuna Therapeutics (KRTX) Presents At Wedbush PacGrow Healthcare Conference - Slideshow |
| Aug 12 |
90 Biggest Movers From Friday |
| Aug 8 |
Karuna Therapeutics reports Q2 results |
| Aug 8 |
Karuna Therapeutics Reports Second Quarter 2019 Financial Results and Provides General Business Update |
| Aug 6 |
Karuna Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference |
| Jul 23 |
Achillion Pharmaceuticals among healthcare gainers; Marinus Pharmaceuticals leads the losers |
| Jul 23 |
Sell-siders bullish on Karuna Therapeutics in premarket action |
| Jul 20 |
The Week Ahead In Biotech: Pharma Earnings Pick Up Pace |
| Jul 5 |
The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight |
| Jul 5 |
48 Biggest Movers From Wednesday |
| Jul 2 |
Karuna Therapeutics Inc (KRTX) President & CEO Steven M Paul Bought $230,400 of Shares |
| Jul 2 |
Karuna closes $103M IPO |
| Jul 2 |
Karuna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares |
| Jun 28 |
Karuna Therapeutics Opens Above IPO Price |
| Jun 28 |
Karuna Therapeutics prices IPO at $16 midpoint |
| Jun 27 |
Karuna Therapeutics Announces Pricing of Upsized Initial Public Offering |
| Jun 27 |
Karuna Therapeutics IPO: What You Need To Know |
